- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02070055
Dietary Correlates of the Maximal Capacity for Fat Oxidation
Dietary Correlates of the Maximal Capacity for Fat Oxidation During Exercise in Males and Females.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The capacity to oxidize (burn) fat as fuel for exercise may have important implications for health and performance. For example, increased fat oxidation could help to induce a negative fat balance and over time improve body composition. Furthermore, increasing the oxidation of fat could spare carbohydrate utilization during exercise which should improve endurance performance by preserving the bodies limited carbohydrate reserves for the latter stages of competition. Interestingly, there is substantial individual variation in the balance of fuels used for energy during exercise and in particular the maximal capacity to oxidize fat (MFO). Whilst habitual diet is known to affect the metabolic response to exercise, the influence of nutrition on the individual variability observed in maximal fat oxidation has not been comprehensively studied.
Therefore, the proposed investigation aims to build on current understanding of how various nutritional factors influence MFO during exercise. Based on previous small intervention studies, it is suspected that energy balance and macronutrient content or distribution may exert the strongest influence on MFO during exercise. Specifically, the main hypothesis would be that negative energy balance; higher fat intake and/or low carbohydrate intake would be the strongest positive influencer's of MFO. Nonetheless, the determination of an array of habitual and acute nutrient intake data in a relatively large cohort of healthy individuals will enable an insight into the influence of a comprehensive array of nutrients on MFO during exercise. With a greater understanding of the nutritional factors that influence MFO during exercise, new nutritional interventions can be designed to promote the oxidation of fat for improved health and performance.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B15 2TT
- University of Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: 18 - 45 years of age
Sex: Men and women*
* Women must be eumenorrheic and regularly menstruating or using hormonal contraception
- BMI: 18.8-29.9 kg/m2
- Diagnosis / General Health: Good general health and accustomed to normal levels of activity as assessed by the School of Sport and Exercise Sciences General Health Questionnaire
- Compliance: understands and is willing, able and likely to comply with all study procedures and restrictions.
- Consent: demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
Exclusion Criteria:
- Women who are known to be pregnant
- Women who are breast feeding
- Current or recent (last 3 months) participation in another clinical or intervention trial.
- Concomitant Medication. Prescription or non-prescription medication that may interfere with metabolism or substrate utilisation (including beta-blockers, insulin, bronchodilators, anti-inflammatory agents, thyroxine and medications/supplements that in the opinion of the investigator may affect metabolism).
- Substance abuse (within the last 1 years)
- Completely sedentary individuals as assessed by the School of Sport and Exercise Sciences General Health Questionnaire
- Consumption of alcohol 24 hours prior to Visit 2
- Current or recent (within the last 30 days) smoker
- Engaged in prolonged periods of food abstinence (e.g., for health or religious reasons) that may influence the normal metabolic response to exercise
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
No treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Maximal Fat Oxidation in grams per minute
Time Frame: From any 10 second interval from a 30 minute exercise test
|
To determine the extent to which the habitual diet influences the maximal rate of fat oxidation during exercise in healthy men and women
|
From any 10 second interval from a 30 minute exercise test
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gareth A Wallis, Dr, University of Birmingham
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RG_12-251
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maximal Rate of Fat Oxidation
-
Northumbria UniversityCompletedExercise Fat OxidationUnited Kingdom
-
Tuba MelekoğluCompletedHeart Rate Variability | Body Fat | Wrestling | Fitness TestingTurkey
-
Wageningen UniversityTaylor's UniversityCompletedTaste Perception | Fat Sensation | Eating Rate | Bite Size
-
Universität des SaarlandesCompletedHealth Status | Maximal and Submaximal Parameters of Physical PerformanceGermany
-
Laval UniversityFonds de la Recherche en Santé du Québec; Canada Foundation for InnovationCompletedExercise | COPD | Endurance Shuttle Walking Test (Exercise at 85% of Maximal Shuttle Walking Test)Canada
-
Life Detection TechnologiesNilo Medical Consulting GroupRecruiting
-
University Hospital, BrestCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Zeltiq AestheticsCompleted
-
Shaare Zedek Medical CenterUnknownFat Necrosis of Breast
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted